Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07641023
What this trial is testing

Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdvanced/Metastatic
Beijing Biotech 60
Not applicableUnknownNCT03051542
What this trial is testing

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Peking University Cancer Hospital & Institute 60
Very early researchUnknownNCT04209712
What this trial is testing

Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease

Who this might be right for
Acute Myeloid Leukemia
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China 6
Testing effectiveness (Phase 2)Study completedNCT06006403
What this trial is testing

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Acute Myeloid LeukemiaBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Relapse Leukemia+1 more
Chongqing Precision Biotech Co., Ltd 5
Testing effectiveness (Phase 2)Study completedNCT02854839
What this trial is testing

MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
GC Cell Corporation 78
Early research (Phase 1)UnknownNCT05108012
What this trial is testing

Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

Who this might be right for
Glioblastoma MultiformRecurrent Glioblastoma
Royan Institute 5
Not applicableUnknownNCT04286477
What this trial is testing

The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT

Who this might be right for
End Stage Renal Disease on Dialysis
University of Ioannina 45
Early research (Phase 1)Study completedNCT06296056
What this trial is testing

Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)

Who this might be right for
Solid TumorsMetastatic
Seoul Hospital 9
Not applicableStudy completedNCT00187096
What this trial is testing

Natural Killer (NK) Cell Transplantation for AML

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT06251973
What this trial is testing

AgenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

Who this might be right for
Metastatic Esophageal CarcinomaAdvanced Unresectable Gastric AdenocarcinomaMetastatic Gastric Cancer+10 more
Memorial Sloan Kettering Cancer Center 20
Not applicableLooking for participantsNCT03394053
What this trial is testing

The Mechanistic Biology of Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 2,500
Early research (Phase 1)UnknownNCT04107142
What this trial is testing

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Who this might be right for
Colorectal CancerTriple Negative Breast CancerSarcoma+3 more
CytoMed Therapeutics Pte Ltd 10
Testing effectiveness (Phase 2)Ended earlyNCT05296525
What this trial is testing

Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL

Who this might be right for
Non-Hodgkin Lymphoma
Gamida Cell ltd 13
Testing effectiveness (Phase 2)Study completedNCT01238159
What this trial is testing

Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Samsung Medical Center 30
Early research (Phase 1)Temporarily pausedNCT01974479
What this trial is testing

Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
National University Health System, Singapore 20
Early research (Phase 1)WithdrawnNCT04808115
What this trial is testing

IIT PH1 KDS-1001 in Patients With CML

Who this might be right for
CML (Chronic Myelogenous Leukemia
Duke University
Not applicableStudy completedNCT07692607
What this trial is testing

Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
LucasBio 25
Testing effectiveness (Phase 2)Study completedNCT01904136
What this trial is testing

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Gene Mutations+6 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)WithdrawnNCT04797975
What this trial is testing

Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19

Who this might be right for
Covid19
Kiadis Pharma
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Next Page